Antistax

01/01/2012 - "The obtained results demonstrated undoubted efficacy of Antistax administered at early stages of postmastectomic lymphedema. "
01/01/2012 - "Analysed herein are the results of two-year treatment with Antistax of 50 female patients presenting with early stages of upper limb lymphedema (the 'preclinical' stage of 'transient' oedemas, mild-oedema stage). "

01/01/2010 - "It was determined that administration of Antistax at daily doses of 360 and 720 mg for 2 months resulted in a significant decrease in the volume of the affected extremity, which was accompanied by regression of complaints related to venous insufficiency. "
01/01/2007 - "It was shown that Antistax attenuates main symptoms of chronic venous insufficiency and improves the quality of life."
01/01/2006 - "[Pathophysiological mechanisms of lower limb chronic venous insufficiency and possibility of its correction with Antistax]."
12/01/2015 - "This 8-week registry study was a comparative evaluation of Pycnogenol (French Maritime Pine Bark extract; Horphag Research, Geneva) and Antistax (grape leaf extract [GLE, Boehringer Ingelheim, Germany]) in controlling symptoms of chronic venous insufficiency (CVI). "
12/01/2015 - "A Clinical Comparison of Pycnogenol, Antistax, and Stocking in Chronic Venous Insufficiency."

09/01/2017 - "Antistax results for edema were also good. "

01/01/2010 - "Authors have studied the effect of antistax on the cerebral venous discirculation (VD) in patients with discirculatory encephalopathy. "
01/01/2010 - "[The use of antistax in the treatment of discirculatory encephalopathy]."